Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login
  • Users Online: 665
  • Home
  • Print this page
  • Email this page

   Instructions to the Authors

About the Journal | Aims and Scope | Abstracting/Indexing | Editorial Process | Proposed Time Schedule | Ethical Consideration | Authorship of the Paper | Originality and Plagiarism | Multiple, Redundant or Concurrent Publication | Fundamental Errors in Published Works | Hazards and Human or Animal Subjects | Copies of Any Permission(s) | Human and Animal Rights | Changes to The Authorship | Submission of Manuscripts | Manuscripts Preparation | Short Communications | Sending a Revised Manuscript | Article Processing Charge| Checklist |




About the Journal

Research in Pharmaceutical Sciences (RPS; ISSN: Print -1735-5362, Online - 1735-9414), the journal of School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, I.R. Iran, published by Wolters Kluwer - Medknow Publications, is a peer-reviewed online journal with bimonthly print on demand compilation of issues published. The journal’s full text is available online at rpsjournal.net. The journal allows free access (Open Access) to its contents and permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository. The editors welcome original contributions that have not been published and are not under consideration elsewhere. Authors are encouraged to submit manuscript by our webpage (http://www.journalonweb.com/jrps).

The journal has a distinguished editorial board with extensive academic qualifications, ensuring that the journal maintains high scientific standards and has a broad international coverage. One key request of researchers across the world is open access to research publications.

Aims and Scope

The journal aims at publishing high quality research papers featuring new findings in all aspects of the pharmaceutical sciences. Criteria for publication in RPS are novelty, quality and current interest. Submission requirements specify that papers should be original, unpublished and not under consideration for publication elsewhere. This restriction does not apply to the results published as abstracts of communications, letters to editors, or as contributions to symposia. The journal publishes research reports, review articles, short communications and scientific commentaries on all aspects of the pharmaceutical sciences including Pharmaceutics, Novel drug delivery and targeting systems, Medicinal and Pharmaceutical chemistry, Pharmaceutical and Bilogical Analysis, Pharmcokinetics, Pharmacodynamics, Pharmacology, Pharmacognosy, Pharmacotherapy and Clinical Pharmacy, Pharmacy practice, Pharmacoeconomics, Pharmacoepidemiology, Analytical biochemistry, Pharmaceutical biotechnology, and Molecular modeling.

Abstracting / Indexing

Thomson Reuters ESCI Web of SciencePubMed and PubMed Central and Elsevier Bibliographic Databases. Databases include Scopus, EMBASE, EMCare, EMBiology and Elsevier BIOBASE. It is also indexed in several specialized databases including Scientific Information Database (SID), Google Scholar, Iran Medex, Magiran, Index Copernicus (IC) and Islamic World Science Citation Center (ISC).

Proposed Time Schedule

  • Submission to first editorial decision: 3 weeks
  • Submission to acceptance: 3-6 months
  • Acceptance to publication: 2-6 weeks

Editorial Process

A manuscript will be reviewed for possible publication with the understanding that it is being submitted to RPS alone at that point in time and has not been published anywhere, simultaneously submitted, or already accepted for publication elsewhere. The journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript. All manuscripts received are duly acknowledged. On submission, editors review all submitted manuscripts initially for suitability for formal review. Manuscripts with insufficient originality, serious scientific or technical flaws, or lack of a significant message are rejected before proceeding for formal peer-review. Manuscripts that are unlikely to be of interest to the RPS readers are also liable to be rejected at this stage itself. Manuscripts that are found suitable for publication in RPS are sent to three or more expert reviewers. During submission, the contributor is requested to provide names of two or three qualified reviewers who have had experience in the subject of the submitted manuscript. The reviewers should not be affiliated with the same institutes as the contributor/s. However, the selection of these reviewers is at the sole discretion of the editor. The journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team, who based on the comments from the reviewers takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point by point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated till reviewers and editors are satisfied with the manuscript.

Manuscripts accepted for publication are copy edited for grammar, punctuation, print style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the proofs with corrections (using TRACK CHANGE MODE) within five working days (even if he/she has no corrections). It may not be possible to incorporate corrections received after that period. The whole process of submission of the manuscript to final decision and sending and receiving proofs is completed online.

Ethical Consideration

The Journal is committed to meeting and upholding standards of ethical behavior at all stages of the publication process. We follow closely the industry associations such as the Committee on Publication Ethics (COPE), International Committee of Medical Journal Editors (ICMJE) and World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices in order to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit www.Medknow.com/EthicalGuidelines.asp.

Authorship of the Paper

Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Each contributor should have participated sufficiently in the work to take public responsibility for appropriate portions of the content of the manuscript. The order of naming the contributors should be based on the relative contribution of the contributor towards the study and writing the manuscript. Once submitted the order cannot be changed without written consent of all the contributors.

Originality and Plagiarism

The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others this has been appropriately cited or quoted.

Multiple, Redundant or Concurrent Publication

An author should not in general publish manuscripts describing essentially the same research in more than one journal or primary publication. RPS does not view the following uses of a work as prior publication: publication in the form of an abstract; publication as an academic thesis; publication as an electronic preprint.

Fundamental Errors in Published Works

When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the journal editor and cooperate with the editor to retract or correct the paper. This correction will be published as an erratum.

Hazards and Human or Animal Subjects

Statements of compliance are required if the work involves chemicals, procedures or equipment that has any unusual hazards inherent in their use, or if it involves the use of animal or human subjects.

Copies of Any Permission(s)

It is the responsibility of authors/contributors to obtain permissions for reproducing any copyrighted material including figures, schemes, etc. A copy of the permission obtained must accompany the manuscript. Copies of any and all published articles or other manuscripts in preparation or submitted elsewhere that are related to the manuscript must also accompany the manuscript. It should be noted that articles cannot be published without providing the required permissions. The material should be submitted via the website (http://www.journalonweb.com/jrps) in the Article Files => the Forms section, or sent to the following e-mail address, rps@pharm.mui.ac.ir.

Human and Animal Rights

Investigations using experimental animals must state in the Methods section that the research followed the Principles of Laboratory Animal Care. The authors must seek approval from the appropriate ethical committee. Investigation with human subjects must state in the Methods section that the research followed the tenets of the last update of Declaration of Helsinki and was approved by the institutional human experimentation committee or equivalent, and that informed consent was obtained. Both human and animal researches conducted in Iran should be approved by Iran National Committee for Ethics in Biomedical Research. Authors are kindly requested to provide the approved ethics ID in Materials and Method section of the manuscript.

Changes to The Authorship

Authors are expected to consider carefully the list and order of authors before submitting their manuscript and provide the definitive list of authors at the time of the original submission. Any addition, deletion or rearrangement of author names in the authorship list should be made only before the manuscript has been accepted and only if approved by the journal Editor. To request such a change, the Editor must receive the following from the corresponding author: (a) the reason for the change in author list, (b) written confirmation (e-mail, letter) from all authors that they agree with the addition, removal or rearrangement, and as well as (c) the modified final version of copyright form and first page must be submitted via website or emailed at rps@pharm.mui.ac.ir. In the case of addition or removal of authors, this includes confirmation from the author being added or removed.

Submission of Manuscripts

All manuscripts must be submitted online through the website http://www.journalonweb.com/jrps. First time users will have to register at this site. Registration is free but mandatory. Registered authors can keep track of their articles after logging into the site using their username and password. If you experience any problems, please do not hesitate to contact the journal editorial office by        e-mail at: rps@pharm.mui.ac.ir.

The submitted manuscripts that are not prepared based on  the “Instructions to the Authors” would be returned to the authors for “Technical Modification”, before they undergo editorial/peer-review.

Before submitting a manuscript, please make sure you have the following information to hand in addition to your files: The first and last names and e-mail addresses of all authors and full contact information of any preferred peer reviewers (e-mail address, phone number, institution, and her/his specialty).

The following 4 separate files are required:

1. Title Page / First Page / Covering Letter

This file should contain following information:

  • The type of manuscript (review article, original article, brief communication, case report, letter to the editor, etc.), title of the manuscript, running title, names of all authors / contributors (with their highest academic degrees, designation and affiliations), name(s) of department(s) and/or institution(s), the name of schools/ faculties, the name of university, and country to which the work should be credited. All information which can reveal your identity should be given here. Use text / doc files. Do not zip the files.
  • Contributors should provide a description of contributions, according to aforementioned categories, made by each of them towards the manuscript.
  • Source(s) of support in the form of grants, equipment, drugs, or all of these.
  • Acknowledgment(s), if any. One or more statements should specify 1) contributions that need acknowledging but do not justify authorship, such as general support by a departmental chair; 2) acknowledgments of technical help; and 3) acknowledgments of financial and material support, which should specify the nature of the support. This should be included in the title page of the manuscript and not in the main article file.
  • A full statement to the editor about all submissions and previous reports that might be regarded as redundant publication of the same or very similar work. Any such work should be referred to specifically, and referenced in the new paper. Copies of such material should be included with the submitted paper, to help the editor decide how to handle the matter.
  • Registration number in case of a clinical trial and where it is registered (name of the registry and its URL).
  • A statement of financial or other relationships that might lead to a conflict of interest, if that information is not included in the manuscript itself or in an authors' form.
  • A statement that the manuscript has been read and approved by all the authors, that the requirements for authorship as stated earlier in this document have been met, and that each author believes that the manuscript represents honest work, if that information is not provided in another form.
  • The name, address, academic e-mail, and telephone number of the corresponding author, who is responsible for communicating with the other authors about revisions and final approval of the proofs.

2. Blinded Article File

The main text of the article, beginning from “Abstract” till “References” (all figures, tables, and their corresponding legends could be included at the end of the manuscript file) should be in this file. The file must not contain any mention of the authors' names and affiliation or initials or the institution at which the study was done or acknowledgments. Use doc files. Do not zip the files. Limit the file size to 1 MB. To reduce the size of the file (if file size is large), figures and tables can be submitted as images separately without incorporating them in the article file. The pages should be numbered consecutively, beginning with the first page of the blinded article file.

3. Images

Submit good quality color images of size 4” × 6” and not more than 400 KB size. Images should be uploaded in JPEG, TIFF, BMP, or GIF format. JPEG is most preferred format. Size of the image can be reduced by decreasing the actual height and width of the images. Do not zip the files.

4. The Contributors' / Copyright Transfer Form 

This form should be downloaded from authors’ area on the website (http://www.journalonweb.com/jrps), Downloads Tab; then submitted in original with the signatures of all the contributors at the time of submission from the authors’ area on the abovementioned website.

Manuscript Preparation

All manuscripts should be typed double-spaced with a 12-point font, including references, figure legends and tables, on page with margins of 2.5 cm on all sides. The text of the manuscript must be paginated. The file formats should be in Microsoft Word for Windows. Manuscripts should be assembled in the following order:

ABSTRACT: The abstract should contain a brief account of the question addressed in the paper, the principal methods and results, followed by the main conclusion(s) and must not exceed 250 words. Abbreviations and symbols should be explained in round brackets ( ) on the first use. References should be avoided in the abstract. Authors are requested to assign 3-6 keywords to the manuscript, preferably taken from the Medical Subject Headings (MESH). These keywords should be typed at the end of the abstract. Also the abstract must be structured, under the following sub-headings:

Background and purpose: This must indicate why the study was performed and what question it was intended to answer.

Experimental approach: This should state in outline what experimental methods were used. Details on media, buffers, drug concentrations, time points, statistics, etc., should not be given unless they are important in relation to the question that was addressed.

Findings / Results: The main results relevant to the question addressed should be summarized without quantitative elaboration

Conclusion and implications: As well as summarizing the main implications that follow from the results, and mentioning important shortcomings and caveats, this paragraph must clearly state in what ways the work has advanced understanding in the field.

Introduction: The introduction should give a short and clear account of the background of the problem and the rationale of the investigation. Only previous works that have direct bearing on the present problem should be cited.

Materials and Methods: The methods must be described in sufficient details to allow the experiments to be interpreted and repeated by the readers. Published procedures and techniques should be cited unless significant modifications are involved. The methods are presented in sub-sections, usually defined by the experimental procedure. Exact specification of relevant materials and equipment must be given. Chemical terms must conform to IUPAC rules. Material and Methods section must be accompanied by the name of the manufacturer or distributor, location and state or country. This information must be stated in round brackets in the text, and not as a footnote. The last subsection should provide the methods of data analysis and statistical assessments.

Results: The results may be presented in tables, figures or schemes, which must be referred to in the accompanying text, using appropriate numbering. Tables should be numbered consecutively with Arabic numerals and the number should be followed by a brief descriptive caption, occupying not more than two lines, at the head of the table. Each column should have a heading and the units of measurement should be given in brackets (SI units) in the heading. Figures must be presented on separate pages in consecutive order using Arabic numerals. Each figure should be provided with explanatory information. The legend should be typed separately from the figures. Figures, photographs or computer drawn figures should be original, and of high quality, ready for direct reproduction. Figure legends/captions should be consistent with terminology or nomenclature used in the labeling of the Figures. Tables, figures and legends should not have frame around. Statistical analysis of significance should be performed and for significant differences, the P values should be provided at the most precise level (0.05, 0.01, or 0.001). Authors may be asked to provide the raw data as well as data analyses in connection with a paper for editorial review. Also the authors are highly requested to provide their graphs (either provided using software like Microsoft Excel or GraphPad Prism, or taken from software of an apparatus e.g. HPLC, Flowcytometer, …) according to the following comments:

  • All characters including words, letters, and digits must be written in Times New Roman, un-bold, non-italic with solid black color.
  • An appropriate legend with unit must be defined for both X and Y axes, unit should be provided in parentheses.
  • All lines in a graph including X and Y axes, lines around the columns, error bars, …. must be in solid black color with 1 pt thickness.
  • If a figure has different parts including different graphs or images, therefore different Capital/UPPERCASE letters in Times New Roman, solid black or white (depends on background color), and bold must be assigned to each part at the upper left corner.  

Discussion: The discussion section should contain a brief and pertinent interpretation of the results against the background of existing knowledge. Any assumption on which conclusions are based must be stated clearly. A review-like treatment, which reduces the impact on the reader, should be avoided.

Conclusion: The main conclusions of the study should be presented in a short conclusions section, which should stand alone.

Acknowledgments: The acknowledgements should be brief but should include reference to sources of financial and technical supports.

Conflict of Interest: All authors of article must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interest with products that compete with those mentioned in their manuscript.

If there isn’t any conflict of interest the following statement should be provided: There is no conflict of interest.

Authors’ Contribution: Contributors should provide a description of contributions made by each of them towards the manuscript. Description should be divided in following categories, as applicable: concept, design, definition of intellectual content, literature search, clinical studies, experimental studies, data acquisition, data analysis, statistical analysis, manuscript preparation, manuscript editing and manuscript review. If there are no differences between contributors the following statement could be provided: All authors contributed equally in this work. One or more author should take responsibility for the integrity of the work as a whole from inception to published article and should be designated as 'guarantor'.

References: The references should be cited according to the "Vancouver Style". Using this system, references are numbered in consecutive order that they are cited in the text. For in text citation, parenthesis should be used. References are listed in numerical order at the end of the paper. Journal names are to be abbreviated as they are in the Cumulated Index Medicus. "In press" references may be used only if the journal that has accepted the manuscript is indicated. Personal communications and other unpublished and nonarchival references should not be included in the reference list, in which case the name of the person and date of communication should and the source be cited in parentheses in the text. Examples of references are as follows:


Rezazadeh M, Akbari V, Amuaghae E, Emami J. Preparation and characterization of an injectable thermosensitive hydrogel for simultaneous delivery of paclitaxel and doxorubicin. Res Pharm Sci. 2018;13(3):181-191.

Susidarti RA, Utomo RY, Qodria L, Ramadani RD, Ohta Y, Hattori Y, et al. Preparation of pentagamaboronon-0 and its fructose and sorbitol complexes as boron carrier for boron neutron capture therapy (BNCT) application. Res Pharm Sci. 2019;14(4):286-292.


Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell J. Molecular cell biology. 3rd ed. New York: Scientific American; 1995. pp: 151-178.

Chapter citation:

Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk, CN: Appleton and Lange; 1995. pp. 361-380.


McCormick JB. Apparatus and method for preparing tissue samples for histological examination. United State Patents, 2010. No. US7771992B2.http://www.freepatentsonline.com/7771992.html.

Minyasab SA, Dhamane SP, Hazra P, Iyer H. A method of purifying human growth hormone and purified growth hormone thereof. Google Patents, 2010. Publication No. WO/2010/134084. International application No. PCT/IN2009/000380. https://www.google.com/patents/WO2010134084A1?cl=en.

Also for getting more information, authors could refer to the guidelines below:

National Library of Medicine (NLM)


Short Communications

The short communication should be no more than 1000 words, and could include two figures or tables. It should have at least 15 references. The abstract should not exceed 150 words. Short communications must report completed work, not preliminary findings: they are an alternative format for describing smaller pieces of work.

Sending a Revised Manuscript

The revised version of the manuscript should be submitted online in a manner similar to that used for submission of the manuscript for the first time. When submitting a revised manuscript, contributors are requested to include the referees’ remarks along with point to point clarification. The authors are strongly requested to show changes and modifications in their manuscript using Track Change mode in Microsoft Word Office, which allows reviewers to find out any changes (additions and deletions) easily. Also the Comments File Template should be downloaded from the website, author’s area and then all referees’ comment and questions and author’s answers and explanation must be included in this table. Eventually both revised manuscript and Table of Comments files should be submitted via website (http://www.journalonweb.com/jrps).

Article Processing Charge

All manuscripts submitted to the RPS journal are peer-reviewed in the normal way under editorial control. Authors are asked to follow the details of journal charges and word count limits in the table below. Upon acceptance for publication a processing fee will be payable. Payment of this charge allows RPS to recover its processing, editorial, and production costs. Published papers appear electronically and are freely available from our website. Submitters who tend to pay in Iranian currency are kindly requested to deposit their payments into the account No. 580120000000004975761007 (SHEBA) at Bank Mellat. Please include the specific code (payment ID) for RPS (441130000000049) on your bank receipt. Kindly send a scanned copy of your receipt to the journal via rps@pharm.mui.ac.ir. Contributors out of Iran can electronically pay through secure Medknow, Wolters Kluwer submission portal.

Word Count Limits and Article Processing Charges at One Glance

These numbers show the publication fee according to the word count for Research in Pharmaceutical Sciences (RPS) journal.

  • Additional charges for each extra figure/table are applied as per the occupied space in a page (each full page equals to 500 words).
  • The publication fees are considered as IR Rials for Iranian authors and US Dollars for other nationalities.
  • Upon request for fast tracking of the submitted manuscript, an additional payment of 7,000,000 IRR /250 USD should be considered, with the journal promising to send the decision letter within eight weeks.
  • There are no additional charges for color illustrations.


It is strongly recommended to consider the following checklist while preparing the manuscript.



What's New
Reference style (PPS)
Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal